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Abstract
Embryonic stem cells (ES cells) are powerful tools for genetic engineering and hold significant
potential for regenerative medicine. Recent work provides new insights into ES cell pluripotency
and delineates separate transcriptional pathways in ES cells for maintenance of the undifferentiated
state and for self-renewal. 
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Embryonic stem cells (ES cells) are derived from the inner
cell mass (ICM) of the early mammalian embryo and are dis-
tinguished by two remarkable properties. First, they can be
propagated in tissue culture in an undifferentiated state for
an extended period: that is, they have the property of self-
renewal. Second, when introduced into a host blastocyst they
contribute to all tissues and even the germ cells of the result-
ing chimeric animal: they have the property of pluripotency.
These features have been exploited in studies of early devel-
opment and for the generation of genetically engineered
mice [1]. Recently, the pluripotency and self-renewal of ES
cells have come under close scrutiny. An important goal is an
understanding of the unique pathways used by these cells,
with the intent of recreating them in somatic cells and
thereby reprogramming differentiated cells to an embryonic-
like state. In a recent set of experiments, Ivanova et al. [2]
set out to uncover these pathways by utilizing the latest in
RNAi technology on a genome-wide scale. 
Mouse ES cells in culture require extrinsic factors, such as
leukemia inhibitory factor (LIF), in the culture medium to
maintain the undifferentiated state in vitro. LIF stimulates
the LIF-STAT signaling pathway and operates predomi-
nantly through STAT3 [3,4]. This is in marked contrast to
human ES cells, which do not require LIF-STAT3 signaling
to maintain pluripotency [5]. Other extrinsic signals, such as
bone morphogenetic protein (BMP) acting through the
BMP-SMAD [6] pathways, contribute to self-renewal and
pluripotency of mouse ES cells in vitro. 
Transcription factors for self-renewal and
differentiation
Key transcription factors have also been identified that form
an intrinsic core regulatory circuit that maintains mouse ES
cells in the pluripotent state in vitro. Of these, Oct4, an atyp-
ical homeodomain protein, was originally cloned on the
basis of its highly restricted expression pattern; it is
expressed exclusively in murine ES cells, ICM and germ cells
[7]. Oct4-deficient murine ES cells differentiate into tro-
phectoderm and fail to form all three germ layers (meso-
derm, ectoderm and endoderm) [8]. Sox2 is an HMG-family
protein that occupies many gene targets with Oct4 and is
also required to form the ICM [9]. A recent addition to the
‘pluripotency factors’ is Nanog, another atypical homeo-
domain protein related to the Nkx subfamily. Forced expres-
sion of Nanog in ES cells lifts the requirement for LIF to
maintain pluripotency, suggesting that Nanog is a major reg-
ulator of the pluripotent state [5,10,11]. Through genome-
wide chromatin immunoprecipitation followed by DNAmicroarray analysis (ChIP-chip) [12] or ChIP-PET [13]
experiments (based upon high-throughput sequencing to
determine gene expression patterns), numerous target genes
bound by Nanog, Oct4 and Sox2 have been identified. These
factors appear to act combinatorially to regulate a limited
repertoire of target genes, thereby forming a tight transcrip-
tional regulatory circuit that maintains ES cells in a pluripo-
tent state.
Nanog’s distinguishing role in the maintenance of murine ES
cells in vitro is an ability to bypass the requirement for the
LIF-STAT pathway [5]. In addition, fusion experiments with
mouse cells have shown the dominance of the ES cell pheno-
type over that of somatic cells, implying that proteins in the
nucleus of ES cells are able to reprogram more differentiated
cells to an embryonic-like state [14]. The full repertoire of
factors involved in establishing or maintaining pluripotency,
and also competent to reprogram cells, is unknown and,
until recently, there had been no comprehensive effort to
delineate factors necessary for the maintenance of the mouse
ES cell in vitro phenotype. Ihor Lemischka and his col-
leagues [2] have now tackled just this issue using a func-
tional genomics approach designed to identify novel factors
required for self-renewal in mouse ES cells. They began with
microarray data from mouse ES cells as they progress from
an undifferentiated state into cells representing all three
germ layers upon retinoic-induced differentiation [2], and
hypothesized that factors required for pluripotency and self-
renewal would be rapidly downregulated. Of 901 downregu-
lated genes, 65 DNA-binding proteins or transcription
factors were selected for further functional analysis. 
Ivanova et al. [2] then assessed the effects of the loss of each
of these proteins on the ES cells’ capacity for self-renewal.
To do this they devised an assay in which wild-type ES cells
were mixed with ES cells transduced with lentiviruses con-
taining short hairpin RNAs (shRNAs) to trigger RNA inter-
ference (RNAi), along with an expressed green fluorescent
protein (GFP) marker. Compromised self-renewal would be
reflected in a decreasing percentage of GFP-marked cells in
the culture. Six genes were identified by this assay and were
characterized further for their effects on mouse ES cell
pluripotency. Among these six were the ‘old friends’ Nanog,
Oct4 and  Sox2, consistent with substantial previous evi-
dence in support of their roles as core self-renewal factors.
The three other genes were Esrrb, Tcl1 and Tbx3. To further
characterize the possible roles of these genes, Ivanova et al.
[2] carried out extensive marker-gene analysis following the
shRNA inhibition. These experiments revealed that each
factor appeared to repress distinct differentiation programs,
although there was significant overlap. 
Further characterization by microarray analysis revealed
three distinct patterns of gene expression on knockdown.
The expression of approximately 771 genes appeared inde-
pendent of gene knockdown; expression of 474 genes was
either up- or downregulated by knockdown of Nanog, Oct4
or  Sox2, but unaffected by knockdown of Esrrb,  Tbx3 or
Tcl1; and the expression of 272 genes was upregulated by the
loss of Esrrb, Tbx3 and Tcl1, but unperturbed by inhibition
of Nanog, Oct4 and Sox2. These data provide the first evi-
dence in favor of two independent transcriptional pathways
in mouse ES cells; one is controlled by Nanog, Oct4 and
Sox2, and may be predominantly responsible for pluripo-
tency and suppressing differentiation. A second pathway
involving Esrrb, Tbx3 and Tcl1 seems to be responsible for
blocking differentiation along specific cell lineages (Figure
1). Surprisingly, modestly raised levels of Nanog compen-
sated for the loss of Esrrb, Tbx and Tcl1, implying cross-talk
between the two pathways, with Nanog perhaps serving as a
master regulator.
Cellular reprogramming
The elegant work of Ivanova et al. [2] is bold and a technical
tour de force, in that it attempts to be both systematic and
comprehensive in identification of critical factors for self-
renewal and pluripotency. Only subsequent studies using
other approaches will reveal the completeness of the collec-
tion of factors the authors have identified and also the signif-
icance of the different gene-expression patterns revealed
upon shRNA inhibition of Nanog, Oct4 and Sox2 expression
versus knockdown of Esrrb, Tbx3 and Tcl1. The unbiased
genome-wide strategy contrasts with recent experiments by
Austin Smith’s group [15] that focus specifically on the con-
tribution of Nanog to cellular reprogramming in the setting
of mouse ES cell-somatic cell hybrids. Using the activation of
a drug-selection marker under the control of Oct4 regulatory
sequences, these authors [15] examined the frequency of
reprogrammed, ES-like cells arising from fusions of ES cells
with neural stem (NS) cells or more differentiated somatic
cells. Two important observations were made. First, in ES
cell-NS cell hybrids the frequency of reprogramming was
markedly enhanced by modestly increasing Nanog expres-
sion. This is consistent with the view that Nanog is a major
driver of pluripotency. Second, the frequency of repro-
grammed cells was much lower in ES cell-fibroblast hybrids,
implying that the epigenetic ‘state’ of the differentiated
partner is a determinant of the ease with which the tran-
scriptional program can be reset [15]. 
Although Smith’s [15] and Lemischka’s [2] groups used dif-
ferent approaches, some common conclusions emerge. Their
findings underscore the importance of Nanog in maintaining
the phenotype of mouse ES cells and in reprogramming
other cell types into pluripotent cells. These studies show
that the level of Nanog is critical in both settings. Indeed,
dose-dependent actions of pluripotency factors appear to be
a general feature of development. For example, raised levels
of Oct4 promote differentiation into primitive endoderm
and mesoderm, whereas reduced expression of Oct4 pro-
motes trophectoderm development [16,17]. Such results
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in determining cell fate, and these transcription factors will
warrant closer scrutiny as additional factors are implicated
in pluripotency. 
The gradation of transcription factor levels may represent an
additional level of complexity by which ES cells employ a
limited number of transcription factors to regulate pluripo-
tency. In addition, Ivanova et al. [2] are the first to suggest
two distinct transcriptional pathways involved in blocking
differentiation and promoting self-renewal. The work of
Smith’s group [15], however, clearly points to the differentia-
tion state of a cell as critical to its propensity for be repro-
grammed by nuclear factors - implying that the epigenetic
state of the more differentiated nucleus needs to be consid-
ered in future studies. These two papers point to an impor-
tant set of factors, all of which have a critical role in
pluripotency and/or self-renewal. Nonetheless, much more
will be required to understand how these factors function
and the degree of cross-talk between them. Further studies
will undoubtedly center on the minimum set(s) of factors
required to reprogram different types of somatic cells to a
mouse ES cell-like state, as demonstrated by the work of
Takahashi and Yamanaka [18]. We can envisage a time in
when cellular reprogramming may become routine and
applied in regenerative medicine.
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Figure 1
A schematic view of the transcriptional pathways involved in self-renewal
and blocking differentiation of murine embryonic stem cells. Self-renewal
appears to be regulated by two distinct transcriptional pathways, one
involving Esrrb, Tcl1 and Tbx3 and a separate pathway involving Nanog,
Oct4 and Sox2, with some degree of cross-talk. Differentiation pathways
appear to be separately regulated as well. Nanog, Oct4 and Sox2
cooperate to block trophectoderm and endoderm differentiation,
whereas Nanog, Sox2, Esrrb, Tcl1 and Tbx3 cooperate to prevent
formation of the epiblast. Raised levels of Nanog on its own appear able
to compensate for the loss of Esrrb, Tcl1 or Tbx3 for both self-renewal
and blocking differentiation. 
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